Summary:
- This article discusses the development of a new vaccine against the SARS-CoV-2 virus, which causes COVID-19.
- The vaccine uses a novel approach by targeting the virus's nucleocapsid (N) protein, in addition to the spike (S) protein, which is the target of most current COVID-19 vaccines.
- Targeting the N protein in addition to the S protein may provide broader and more durable protection against SARS-CoV-2 and its variants, as the N protein is more conserved across different strains of the virus.